Apollo Endosurgery Inc logo

Apollo Endosurgery Inc (APEN)

Market Closed
3 Apr, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
10. 00
0
0%
$
579.72M Market Cap
- P/E Ratio
- Div Yield
1.64M Volume
- Eps
$ 10
Previous Close
Add Transaction
Day Range
9.92 10
Year Range
3.49 10.3
Want to track APEN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

APEN closed Monday higher at $10, an increase of 0% from Friday's close, completing a monthly increase of 0% or $10. Over the past 12 months, APEN stock gained 0%.
APEN is not paying dividends to its shareholders.
Apollo Endosurgery Inc has completed 3 stock splits, with the recent split occurring on Dec 30, 2016.
The company's stock is traded on one exchange.

APEN Chart

People also search for

GH Research plc
$ 29.08
-1.5239%
Iovance Biotherapeutics, Inc.
$ 6.49
+1.4062%
Eventide Healthcare & Life Sciences Fund Class A Shares
$ 56.93
-0.9051%
Ocular Therapeutix Inc.
$ 9.76
+5.6277%
Kardigan, Inc.
$ 22.06
+4.649%

Apollo Endosurgery Inc (APEN) FAQ

What is the stock price today?

The current price is $10.00.

On which exchange is it traded?

Apollo Endosurgery Inc is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is APEN.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 579.72M.

Has Apollo Endosurgery Inc ever had a stock split?

Apollo Endosurgery Inc had 3 splits and the recent split was on Dec 30, 2016.

Apollo Endosurgery Inc Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Charles S. McKhann CEO
NASDAQ (NMS) Exchange
03767D108 CUSIP
US Country
202 Employees
- Last Dividend
30 Dec 2016 Last Split
- IPO Date

Overview

Apollo Endosurgery, Inc. is a prominent medical technology firm that focuses on the innovation, development, and commercialization of cutting-edge medical instruments. Established in 2005 and headquartered in Austin, Texas, the company specializes in providing sophisticated solutions that empower healthcare professionals to perform advanced endoscopic procedures effectively. The company’s extensive portfolio includes products designed for various medical applications, particularly in the fields of gastrointestinal health and weight management. Apollo Endosurgery, Inc. delivers its medical solutions to a wide range of healthcare providers, including hospitals, outpatient surgical centers, clinics, and individual physicians, serving markets in the United States, Australia, Costa Rica, and several European countries.

Products and Services

  • OverStitch Endoscopic Suturing Systems

    The OverStitch and OverStitch Sx systems enable physicians to perform advanced endoscopic procedures through suturing and securing tissue approximation via a flexible endoscope. These systems allow for enhanced treatment options and are integral in complex gastrointestinal procedures.

  • Orbera Intragastric Balloon System

    Offered under multiple brands, including the BIB and Orbera365 Managed Weight Loss System, the Orbera system assists patients in weight management by reducing gastric capacity and slowing down the process of gastric emptying. This innovative solution leads to decreased food intake, thus aiding in weight loss efforts.

  • X-Tack Endoscopic HeliX Tacking System

    This suture-based device is designed to repair defects within both the upper and lower gastrointestinal tracts. The X-Tack system offers a reliable and effective solution for treating various gastrointestinal issues, enhancing patient outcomes.

Contact Information

Address: Building 1
Phone: 512 279 5100